Meridian Bioscience Inc. (VIVO) Shares Active after Upgrade at Zacks Investment Research

Meridian Bioscience Inc. (NASDAQ: VIVO) shares slid back in value on Tuesday January 17 on lighter trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, in early trade, the Dow Jones Industrial Average was 47 points lower, or 0.24% to 19838, the S&P 500 fell 7 points, or 0.29% to 2267, while the Nasdaq was down 19 points, or 0.35% to 5554.

Are your Sotck Market Investments Paying Off ?

Analysts at Zacks Investment Research upgraded shares of Meridian Bioscience Inc. (NASDAQ: VIVO) from Sell to Hold today. The company currently has a rating of Hold on the stock. As a means of comparison, a number of other analysts have commented on the stock in recent days, and Meridian Bioscience Inc. has secured a consensus one-year price target of $17.25, above the opening price of $16.95, a difference of 10.18 percent. Meridian Bioscience Inc. stock has a 52-week high of $21.49. Stock prices sometimes get a boost to the upside when analysts upgrade a stock.

Shares of Meridian Bioscience Inc. (NASDAQ: VIVO) opened at $16.95 yesterday and traded in a range between, $16.80 and $17.00, and last traded at $16.95, which is a drop of $0.15 over the previous closing price.

Meridian Bioscience Inc. (NASDAQ: VIVO) now has a market cap of 713.73M.

Meridian Bioscience Inc. (NASDAQ: VIVO) Average Daily Trading Volume

35,657 shares crossed the trading desk yesterday, 110 percent below the norm, out of a total float 41,437,000. lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use increases in trading volume to identify heavy volume accumulation or distribution by institutional investors.

As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain substantial teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.

Meridian Bioscience Inc. (NASDAQ: VIVO) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

With that in mind, Meridian Bioscience Inc. (NASDAQ: VIVO) now has a 50-day MA of $17.64 and 200-day MA of $18.57. It has traded in a 52-week range between $15.75 – 21.49 and today’s last price is 21.13%% lower than the 52 week high of $21.49.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors seek companies that have grown their earnings at least 25% or more over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply